Your browser doesn't support javascript.
loading
Characterisation of Staphylococci species from neonatal blood cultures in low- and middle-income countries.
Sands, Kirsty; Carvalho, Maria J; Spiller, Owen B; Portal, Edward A R; Thomson, Kathryn; Watkins, William John; Mathias, Jordan; Dyer, Calie; Akpulu, Chinenye; Andrews, Robert; Ferreira, Ana; Hender, Thomas; Milton, Rebecca; Nieto, Maria; Zahra, Rabaab; Shirazi, Haider; Muhammad, Adil; Akif, Shermeen; Jan, Muhammad Hilal; Iregbu, Kenneth; Modibbo, Fatima; Uwaezuoke, Stella; Chan, Grace J; Bekele, Delayehu; Solomon, Semaria; Basu, Sulagna; Nandy, Ranjan Kumar; Naha, Sharmi; Mazarati, Jean-Baptiste; Rucogoza, Aniceth; Gaju, Lucie; Mehtar, Shaheen; Bulabula, Andre N H; Whitelaw, Andrew; Walsh, Timothy R.
Afiliação
  • Sands K; Department of Medical Microbiology, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK. kirsty.sands@zoo.ox.ac.uk.
  • Carvalho MJ; Department of Zoology, Ineos Oxford Institute of Antimicrobial Research, Oxford, UK. kirsty.sands@zoo.ox.ac.uk.
  • Spiller OB; Department of Medical Microbiology, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Portal EAR; Institute of Biomedical Sciences, Department of Medical Sciences, University of Aveiro, Aveiro, Portugal.
  • Thomson K; Department of Medical Microbiology, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Watkins WJ; Department of Medical Microbiology, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Mathias J; Department of Medical Microbiology, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Dyer C; Department of Zoology, Ineos Oxford Institute of Antimicrobial Research, Oxford, UK.
  • Akpulu C; Department of Medical Microbiology, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Andrews R; Department of Medical Microbiology, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Ferreira A; Department of Medical Microbiology, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Hender T; Centre for Trials Research, Cardiff University, Cardiff, UK.
  • Milton R; Department of Medical Microbiology, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Nieto M; Department of Zoology, Ineos Oxford Institute of Antimicrobial Research, Oxford, UK.
  • Zahra R; National Hospital Abuja, Abuja, Nigeria.
  • Shirazi H; Department of Medical Microbiology, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Muhammad A; Department of Medical Microbiology, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Akif S; Department of Medical Microbiology, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Jan MH; Department of Medical Microbiology, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Iregbu K; Centre for Trials Research, Cardiff University, Cardiff, UK.
  • Modibbo F; Department of Medical Microbiology, Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK.
  • Uwaezuoke S; Department of Microbiology, Quaid-I-Azam University, Islamabad, Pakistan.
  • Chan GJ; Pakistan Institute of Medical Sciences, Islamabad, Pakistan.
  • Bekele D; Department of Microbiology, Quaid-I-Azam University, Islamabad, Pakistan.
  • Solomon S; Department of Microbiology, Quaid-I-Azam University, Islamabad, Pakistan.
  • Basu S; Department of Microbiology, Quaid-I-Azam University, Islamabad, Pakistan.
  • Nandy RK; National Hospital Abuja, Abuja, Nigeria.
  • Naha S; Murtala Muhammad Specialist Hospital, Kano, Nigeria.
  • Mazarati JB; Federal Medical Centre Jabi, Abuja, Nigeria.
  • Rucogoza A; Division of Medical Critical Care, Boston Children's Hospital, Boston, MA, USA.
  • Gaju L; Department of Epidemiology, Harvard T.H Chan School of Public Health, Boston, MA, USA.
  • Mehtar S; Department of Obstetrics and Gynecology, St Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
  • Bulabula ANH; Department of Microbiology, Immunology and Parasitology, St Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia.
  • Whitelaw A; Division of Bacteriology, ICMR-National Institute of Cholera and Enteric Diseases Beliaghata, Kolkata, India.
  • Walsh TR; Division of Bacteriology, ICMR-National Institute of Cholera and Enteric Diseases Beliaghata, Kolkata, India.
BMC Infect Dis ; 22(1): 593, 2022 Jul 01.
Article em En | MEDLINE | ID: mdl-35790903
BACKGROUND: In low- and middle-income countries (LMIC) Staphylococcus aureus is regarded as one of the leading bacterial causes of neonatal sepsis, however there is limited knowledge on the species diversity and antimicrobial resistance caused by Gram-positive bacteria (GPB). METHODS: We characterised GPB isolates from neonatal blood cultures from LMICs in Africa (Ethiopia, Nigeria, Rwanda, and South Africa) and South-Asia (Bangladesh and Pakistan) between 2015-2017. We determined minimum inhibitory concentrations and performed whole genome sequencing (WGS) on Staphylococci isolates recovered and clinical data collected related to the onset of sepsis and the outcome of the neonate up to 60 days of age. RESULTS: From the isolates recovered from blood cultures, Staphylococci species were most frequently identified. Out of 100 S. aureus isolates sequenced, 18 different sequence types (ST) were found which unveiled two small epidemiological clusters caused by methicillin resistant S. aureus (MRSA) in Pakistan (ST8) and South Africa (ST5), both with high mortality (n = 6/17). One-third of S. aureus was MRSA, with methicillin resistance also detected in Staphylococcus epidermidis, Staphylococcus haemolyticus and Mammaliicoccus sciuri. Through additional WGS analysis we report a cluster of M. sciuri in Pakistan identified between July-November 2017. CONCLUSIONS: In total we identified 14 different GPB bacterial species, however Staphylococci was dominant. These findings highlight the need of a prospective genomic epidemiology study to comprehensively assess the true burden of GPB neonatal sepsis focusing specifically on mechanisms of resistance and virulence across species and in relation to neonatal outcome.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Staphylococcus aureus Resistente à Meticilina / Sepse Neonatal Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Newborn País como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Staphylococcus aureus Resistente à Meticilina / Sepse Neonatal Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Newborn País como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article